Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Diabetes Care
|
August 28, 2023
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants
Leah E Cahill, Rachel A Warren, Allie S Carew, et al.
American Journal of Preventive Cardiology
|
May 27, 2024
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial
Leah E Cahill, Rachel A Warren, Gideon D Bahn, et al.
Diabetes Care
|
November 17, 2021
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial
Rachel A Warren, Allie S Carew, Pantelis Andreou, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 11, 2025
Haptoglobin Phenotype and Cardiovascular Risk: The ACCORD Blood Pressure RCT
Samantha K Lavallée, Allie S Carew, Rachel A Warren, et al.
Journal of the American Heart Association
|
September 30, 2023
Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study
Rachel A Warren, Allie S Carew, Pantelis Andreou, et al.
Cardiovascular Diabetology
|
February 24, 2024
Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study
Rachel A Warren, Michael P Bancks, Allie S Carew, et al.
BMJ Open Diabetes Research & Care
|
May 6, 2025
Relationship between time-varying achieved HbA<sub>1c</sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study
Leah E Cahill, Rachel A Warren, Samantha K Lavallée, et al.
Diabetes Care
|
March 14, 2024
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study
Leah E Cahill, Rachel A Warren, Allie S Carew, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 12, 2022
Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort
Mark P Steele, Anna L Peljto, Susan K Mathai, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Diabetes Care
|
August 28, 2023
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants
Leah E Cahill, Rachel A Warren, Allie S Carew, et al.
American Journal of Preventive Cardiology
|
May 27, 2024
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial
Leah E Cahill, Rachel A Warren, Gideon D Bahn, et al.
Diabetes Care
|
November 17, 2021
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial
Rachel A Warren, Allie S Carew, Pantelis Andreou, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 11, 2025
Haptoglobin Phenotype and Cardiovascular Risk: The ACCORD Blood Pressure RCT
Samantha K Lavallée, Allie S Carew, Rachel A Warren, et al.
Journal of the American Heart Association
|
September 30, 2023
Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study
Rachel A Warren, Allie S Carew, Pantelis Andreou, et al.
Cardiovascular Diabetology
|
February 24, 2024
Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study
Rachel A Warren, Michael P Bancks, Allie S Carew, et al.
BMJ Open Diabetes Research & Care
|
May 6, 2025
Relationship between time-varying achieved HbA<sub>1c</sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study
Leah E Cahill, Rachel A Warren, Samantha K Lavallée, et al.
Diabetes Care
|
March 14, 2024
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study
Leah E Cahill, Rachel A Warren, Allie S Carew, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 12, 2022
Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort
Mark P Steele, Anna L Peljto, Susan K Mathai, et al.
Page
of 1